Posted on November 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on September 9, 20249/9/24
Tumor Types Drive Oncology Product Launch Strategies
Posted on June 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on March 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on February 19, 20242/19/24
Navigating Successful Partnerships in the Pharmaceutical Industry: Insights from Shorla Oncology CEO Sharon Cunningham
Posted on July 18, 20237/18/23
Specialty Pharmacies are Ready for the Biosimilar Boom. Are you?
Posted on July 13, 20237/13/23
Overcoming the Commercialization Challenges of Personalized Cancer Immunotherapies
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on May 31, 20235/31/23